Surgical treatment for ischemic heart disease with other arteriosclerotic vascular diseases.

Quality of life in patients with ischemic heart disease

Background and Purpose: Ischemic Heart Diseases (IHD) is getting as the most common and the main causes of heart diseases and mortalities worldwide affecting the quality of life (QOL) of the patients. This study was conducted to determine the QOL for the patients with IHD referring to medical centers of Kashan in 2007. Methods: This cross-sectional study was performed on all patients (n =500) ...

Higher blood pressure as a risk factor for diseases other than stroke and ischemic heart disease.

Arteriosclerotic vascular disease and testicular fibrosis.

THE PURPOSE of this paper is to report an interesting inverse relationship between arteriosclerotic vascular disease and advanced testicular fibrosis. In recent years increasing attention has been paid to the possible role of gonadal hormones in the pathogenesis of arteriosclerosis.1 2 It has long been suspected that high estrogen levels proteet premenopausal women from the development of arter...

تاثیر آلوپورینول بر رویoutcome بیماران ischemic heart disease بستری در ccu

چکیده مقدمه: بیماری های ایسکمیک قلب با ویژگی کاهش خون رسانی به ماهیچه قلب، به علت بیماری های عروق کرونر از جمله آترواسکلروز ایجاد می شود. از افزایش فعالیت گزانتین اکسیداز نیز منجر به عدم کارایی عروق در خون رسانی به عضله ی قلب و ایجاد انواع ایسکمی و آسیبهای بافتی و عروقی می شود. به نظر می رسد، داروهای مهارکننده گزانتین اکسیداز از طریق افزایش شرب بافتی در بهبود علائم بیماری های ایسکمیک قلب موثر ...

Surgical Treatment for Heart Failure in Ischemic Cardiomyopathy

Background: Cardiac transplantation remains the gold standard of surgical therapies for severe LV dysfunction ischemic cardiomyopathy. However, the Achilles heel of heart transplantation is the shortage of organ donors. Thus, nontransplant surgical alternatives are necessary to treat many of the patients who progress to intractable Class III, or especially Class IV, heart failure. Methods: Two ...